Jessica P. Cerdeña

Dr. Jessica P. Cerdeña

Yale University, New Haven, Connecticut, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in The Lancet
Verified
Journal Article
Open access
JCJessica P. Cerdeña
Jessica P. Cerdeña
MPMarie V Plaisime
Marie V Plaisime
JTJennifer Tsai
Jennifer Tsai

1 February 2021 in Social Science & Medicine
Verified
Journal Article
Closed access
JCJessica P. Cerdeña
Jessica P. Cerdeña
LRLuisa M. Rivera
Luisa M. Rivera
JSJudy M. Spak
Judy M. Spak

19 May 2022 in Human Genomics
Verified
Journal Article
Open access
PDF file
JCJessica P. Cerdeña
Jessica P. Cerdeña
VGVanessa Grubbs
Vanessa Grubbs
ANAmy Non
Amy Non
Background: Recent studies have reignited the tinderbox of debate surrounding the use of race and ancestry in medicine. These controversial studies have argued for a strong correlation between genetic ancestry and race, justifying continued use of genetic ancestry measures in studies of disease. These studies contend that increased use of continental ancestry estimates can inform clinical risk assessments and management. Further, recent studies of racial corrections used in clinical algorithms, such as those used to estimate 'normal' lung function, also advocate for use of genetic ancestry in place of race for refining risk algorithms. Main body: These positions are misleading, harmful, and reflect superficial interpretations of population genetics. In this Perspective, we argue that continental genetic ancestry, often proxied by race, serves as a poor indicator of disease risk, and reinforces racialized inequities. Conclusion: Instead, we endorse that racial disparities in disease should be investigated by rigorous measures of structural racism alongside careful measures of genetic factors in relevant disease pathways, rather than relying on genetic ancestry or race as a crude proxy for disease-causing alleles.

19 November 2021 in eClinicalMedicine
Verified
Journal Article
Open access
JTJennifer W. Tsai
Jennifer W. Tsai
JCJessica P. Cerdeña
Jessica P. Cerdeña
WGWilliam Goedel
William Goedel
WAWilliam S. Asch
William S. Asch
VGVanessa Grubbs
Vanessa Grubbs
JKJay S. Kaufman
Jay S. Kaufman
Standard equations for estimating glomerular filtration rate (eGFR) employ race multipliers, systematically inflating eGFR for Black patients. Such inflation is clinically significant because eGFR thresholds of 60, 30, and 20 ml/min/1.73m2 guide kidney disease management. Racialized adjustment of eGFR in Black Americans may thereby affect their clinical care. In this study, we analyze and extrapolate national data to assess potential impacts of the eGFR race adjustment on qualification for kidney disease diagnosis, nephrologist referral, and transplantation listing. Using population-representative cross-sectional data from the United States National Health and Nutrition Examination Survey (NHANES) from 2015-2018, eGFR values for Black Americans were calculated using the Modification of Diet in Renal Disease (MDRD) equation with and without the 1.21 race-specific coefficient using cohort data on age, sex, race, and serum creatinine. Without the MDRD eGFR race adjustment, 3.3 million (10.4%) more Black Americans would reach a diagnostic threshold for Stage 3 Chronic Kidney Disease, 300,000 (0.7%) more would qualify for beneficial nephrologist referral, and 31,000 (0.1%) more would become eligible for transplant evaluation and waitlist inclusion. These findings suggest eGFR race coefficients may contribute to racial differences in the management of kidney. We provide recommendations for addressing this issue at institutional and individual levels. No external funding was received for this study.

19 March 2023 in The Lancet Regional Health - Americas
Verified
Journal Article
Open access
CBCarmen Black
Carmen Black
JCJessica P. Cerdeña
Jessica P. Cerdeña
ESE. Vanessa Spearman-McCarthy
E. Vanessa Spearman-McCarthy

MEMario Alberto Viveros Espinoza-Kulick
Mario Alberto Viveros Espinoza-Kulick
JCJessica P. Cerdeña
Jessica P. Cerdeña
Latinx (im)migrant groups remain underserved by existing mental health resources. Past research has illuminated the complex factors contributing to this problem, including migration-related trauma, discrimination, anti-immigrant policies, and structural vulnerability. This paper uses decolonial-inspired methods to present and analyze results from two studies of Latinx (im)migrant communities in central California and southern Connecticut in the United States. Using mixed quantitative and qualitative analysis, we demonstrate the intersectional complexities to be addressed in formulating effective mental health services. Relevant social and structural factors including knowledge of mental health, access to insurance, and experiencing discrimination were significantly associated with anxiety symptoms, based on linear regression analysis. Ethnographic interviews demonstrate how complex trauma informs mental health needs, especially through the gendered experiences of women. Overlapping aspects of gender, language barriers, fear of authorities, and immigration status contoured the lived experiences of Latinx (im)migrants. Thematic analyses of open-ended survey responses also provide recommendations for solutions based on the experiences of those directly affected by these health disparities, particularly relating to healthcare access, affordability, and capacity. Building from these findings and past research, we recommend the adoption of a comprehensive model of mental health service provision for Latinx (im)migrants that takes into account Indigenous language access, structural competency, expanded health insurance, and resources for community health workers.